For as long as there has been research to cure diabetes, there have been people who believe that a cure will never happen because treating this disease is simply far too profitable. Those who believe in this so-called “conspiracy theory” are convinced that pharma companies have a vested interest in keeping diabetes around as long as possible because peddling their treatments is far bigger business than a cure could ever be.
We all know that…
Read more »
Just a few short years ago, no one could have envisioned the Diabetes Online Community would become what it is today. And be moving in the collaborative direction it’s going…
Seriously, some likely would have laughed at the idea while shaking their heads in disbelief!
It used to be “Us versus Them,” in terms of the relationship between Pharma and people with diabetes (PWDs). There was little interaction; we didn’t know them and they didn’t…
Read more »
Sometimes, diabetes science confuses me.
Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.
Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness and stop the liver from producing too much glucose. Basically, they work by spilling glucose over into the urine which leads to less sugar in your bloodstream. The effect: lower BGs and A1Cs.
Sure, it…
Read more »
When I heard that Lilly Diabetes was holding its first-ever Diabetes Blogger Summit, my initial thought was: “It’s about flippin’ time.”
I’m an active patient advocate and blogger who’s lived in Indianapolis for close to a decade and worked for about six years in downtown Indy, where Lilly is based, but haven’t once been able to get a clear read on what the company is doing to engage the diabetes patient community, either online or…
Read more »
